Although this work provides proof-of-concept evidence on the role of RBC-EVs from patients with diabetes, there is a lost opportunity to study the effects of RBC-derived Arg1 in vivo, a condition which better reflects features of the diabetic microenvironment. The gene discussed is ARG1; the disease is diabetes mellitus.